Cover Image
市場調查報告書

肥胖症治療手術:服務、設備的全球市場

Bariatric Surgery: Global Markets for Services and Devices

出版商 BCC Research 商品編碼 289998
出版日期 內容資訊 英文 165 Pages
訂單完成後即時交付
價格
Back to Top
肥胖症治療手術:服務、設備的全球市場 Bariatric Surgery: Global Markets for Services and Devices
出版日期: 2016年02月08日 內容資訊: 英文 165 Pages
簡介

肥胖治療手術實施推算全球達35萬件以上。胃繞道手術,袖狀胃切除術,胃水球及胃束帶,是全球一般實施的治療。

本報告提供全球肥胖症治療手術市場相關調查、肥胖、糖尿病的疾病詳細調查、主要肥胖症治療手術的種類、併發症、相關設備、手術趨勢與成本的估計各法律規範、應用類型、終端用戶群組、地區市場過去的設備銷售額資料、市場成長的促進因素與阻礙因素、詳細的市場預測、競爭與市場佔有率,及主要企業簡介等等,為您概述為以下內容。

第1章 簡介

第2章 摘要整理

第3章 肥胖概要

  • 疾病概要
  • 肥胖的種類
  • 病因、病理學
  • 風險因素
  • 經濟負擔
  • 流行病學
  • 肥胖治療、管理

第4章 肥胖、第二型糖尿病的種類

  • 肥胖、糖尿病
  • 第二型糖尿病:病因、病理學
  • 症狀與風險因素
  • 流行病學
  • 治療、管理選擇
  • 市場負擔

第5章 肥胖治療手術概要

  • 一般概要
  • 肥胖治療手術的標準
  • 腹腔鏡手術vs.開放性手術
  • 肥胖治療手術的準備
  • 肥胖治療手術的種類
  • 新的肥胖治療手術
  • 肥胖治療手術的優點
  • 肥胖治療手術的風險、併發症
  • 肥胖治療手術的過去、目前趨勢
  • 肥胖治療手術的平均價格
  • 肥胖治療手術:比較分析
  • 肥胖治療手術的歷史

第6章 肥胖治療手術設備概要

  • 肥胖治療手術設備
  • 肥胖治療手術設備的法規情形

第7章 肥胖、第二型糖尿病的未滿足需求

第8章 肥胖治療手術市場評估

  • 肥胖治療手術、服務市場
  • 市場促進成長要素、阻礙要素

第9章 競爭、市場佔有率

第10章 上市、中止、開發中產品

  • 上市產品
  • 中止的產品
  • 開發中產品

第11章 醫療費給付

  • 一般的醫療費給付標準
  • 美國
  • 歐洲
  • 日本
  • 其他

第12章 結論:肥胖治療手術設備的展望

  • 帶給肥胖治療手術市場影響的主要發展
    • 技術開發
    • 人口統計、經濟趨勢
    • 醫療保健產業結構的變化
    • 肥胖治療手術設備、服務的長期展望

第13章 附錄A:簡稱

第14章 附錄B:供應商簡介

第15章 附錄C:產業、專門團體

圖表清單

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HLC153B

The global market for bariatric surgery devices was worth more than $1.2 billion in 2014. The market reached $1.4 billion in 2015 and a projected $2.2 billion by 2020, increasing at a compound annual growth rate (CAGR) of 9.8% from 2015 through 2020.

This report provides:

  • An overview of the global market for services and devices used in the bariatric surgery sector.
  • Analyses of global market trends, with data from 2014, estimates for 2015, and projections of compound annual growth rates (CAGRs) through 2020.
  • Discussion on types of obesity, etiology and pathophysiology, risk factors, economic burden, epidemiology, and obesity treatment and management.
  • An examination of the types and the criteria for bariatric surgeries, along with common complications and the average cost associated with post-surgical complications.
  • A historical perspective on and the current scenario for bariatric surgery procedure.
  • An evaluation of the current clinical challenges, unmet needs, and future outlook.
  • Profiles of major players in the industry.

image1

REPORT SCOPE

SCOPE OF THE REPORT

This report is an analytical business tool with the primary purpose of describing the bariatric surgery and the global market for services and devices. The format of the study is organized around the following topics.

  • Detailed study around diseases like obesity and diabetes.
  • Major types of bariatric procedures (gastric bypass, gastric banding and sleeve gastrectomy), complications and relevant devices (e.g., implanted devices, gastric removal devices and gastric bypass devices).
  • Procedure trends and cost estimates (one-time procedure cost excluding follow-up outpatient monitoring cost).
  • Regulatory structure.
  • Market characterization, unmet need, market size and segmentation, including historical data on sales by application, product type, end-user group and geographical market.
  • Market drivers and restraints.
  • Detailed market projections through 2020.
  • Competition and market shares.
  • Reimbursement.
  • Marketed and pipeline (R&D) products along with description, regulatory status and clinical trials.
  • Observations and conclusions regarding the future of bariatric surgery market for services and devices.
  • Profiles of market participants and associations.

ANALYST'S CREDENTIALS

Dr. Ritu Thakur is the author of this report. She is an independent consultant based in New Delhi, India. She has prior work experience with Panasonic (Healthcare Division) and GlobalData (U.K.-based market research firm). In her previous assignments, she has written many reports on pharmaceutical, medical devices and biotechnology areas.

Table of Contents

CHAPTER 1 INTRODUCTION

  • BARIATRIC SURGERY
  • STUDY BACKGROUND
  • STUDY GOALS AND OBJECTIVES
  • INTENDED AUDIENCE
  • SCOPE OF THE REPORT
  • METHODOLOGY AND INFORMATION SOURCES
  • ANALYST'S CREDENTIALS
  • RELATED BCC RESEARCH REPORTS
  • BCC RESEARCH WEBSITE
  • DISCLAIMER

CHAPTER 2 EXECUTIVE SUMMARY

  • EXECUTIVE SUMMARY
  • SUMMARY TABLE GLOBAL MARKET FOR BARIATRIC SURGERY BY REGION, THROUGH 2020 ($ MILLIONS)
  • SUMMARY FIGURE GLOBAL MARKET FOR BARIATRIC SURGERY BY REGION, 2014-2020 ($ MILLIONS)

CHAPTER 3 OVERVIEW OF OBESITY

  • DISEASE OVERVIEW
    • COMMON TOOLS TO DIAGNOSE OBESITY
      • BMI
      • TABLE 1 BMI CALCULATION
      • Waist Circumference
  • TYPES OF OBESITY
  • TABLE 2 BMI CATEGORIES BASED ON INCREASING HEALTH RISKS
  • ETIOLOGY AND PATHOPHYSIOLOGY
  • FIGURE 1 ENERGY BALANCE, 2014
  • RISK FACTORS
  • ECONOMIC BURDEN
  • EPIDEMIOLOGY
  • TABLE 3 GLOBAL OBESE POPULATION AND SEVERE OBESE POPULATION VS. GENERAL POPULATION, THROUGH 2014 (MILLIONS)
  • FIGURE 2 GLOBAL OBESE POPULATION AND SEVERE OBESE POPULATION, 2008 AND 2014 (% OF GLOBAL GENERAL POPULATION)
  • TABLE 4 U.S. OBESITY AND SEVERE OBESITY VS. GENERAL POPULATION, THROUGH 2014 (MILLIONS)
  • OBESITY TREATMENT AND MANAGEMENT
    • GOALS OF WEIGHT LOSS AND MANAGEMENT
    • WEIGHT MANAGEMENT
    • DIETARY THERAPY
    • PHYSICAL ACTIVITY
    • BEHAVIORAL THERAPY
    • COMBINED THERAPY
    • PHARMACOTHERAPY
    • BARIATRIC SURGERY (WEIGHT-LOSS SURGERY)

CHAPTER 4 OBESITY AND TYPE 2 DIABETES

  • OBESITY AND DIABETES
    • DIABETES MELLITUS (DM)
    • GESTATIONAL DIABETES
    • LATENT AUTOIMMUNE DIABETES IN ADULTS (LADA)
    • FIGURE 3 GLOBAL DIABETES TYPES (% OF TOTAL DIABETES)
  • TYPE 2 DIABETES: ETIOLOGY AND PATHOPHYSIOLOGY
  • DISEASE SYMPTOMS AND RISK FACTORS
  • EPIDEMIOLOGY
  • TABLE 5 GLOBAL DIABETES PREVALENCE, THROUGH 2030 (BILLIONS/%/MILLIONS)
  • TREATMENT AND MANAGEMENT OPTIONS
    • LIFESTYLE CHANGES
    • ANTIOBESITY MEASURES (PHARMACOLOGIC AGENTS)
    • DIABETES MEDICATIONS AND INSULIN THERAPY
    • BARIATRIC SURGERY
  • MARKET BURDEN

CHAPTER 5 OVERVIEW OF BARIATRIC PROCEDURES

  • GENERAL OVERVIEW
  • CRITERIA FOR BARIATRIC SURGERY
  • LAPAROSCOPIC SURGERY VS. OPEN SURGERY
  • FIGURE 4 GLOBAL OPEN VS. LAPAROSCOPIC BARIATRIC SURGERY OCCURRENCE, 2014 (% OF TOTAL BARIATRIC PROCEDURES)
  • BARIATRIC SURGERY PREPARATION
    • DIET MONITORING
    • DIET CONSULTATION
    • PSYCHOLOGICAL CONSULTATION
    • SCREENING BLOOD TESTS
    • INSURANCE COVERAGE
  • TYPES OF BARIATRIC SURGERIES
  • TABLE 6 TYPES OF BARIATRIC SURGERIES
    • MALABSORPTIVE
      • Biliopancreatic Diversion (BPD)
        • Advantages
        • Disadvantages
      • Biliopancreatic Diversion with a Duodenal Switch (BPD-DS)
      • Extended (Distal) Roux-en-Y Gastric Bypass (RYGBP-E)
      • Mini Gastric Bypass
      • Advantages of Malabsorptive Procedures
      • Disadvantages of Malabsorptive Procedures
    • RESTRICTIVE PROCEDURES
      • Sleeve Gastrectomy (SG)
      • Vertical Sleeve Gastrectomy (VSG)
      • Adjustable Gastric Banding (AGB)
      • Gastric Balloons
      • Advantages of Restrictive Procedures
      • Disadvantages of Restrictive Procedures
    • COMBINED RESTRICTIVE/MALABSORPTIVE
      • Gastric Bypass
      • Roux-en-Y Gastric Bypass (RYGB)
      • Advantages of Gastric Bypass
      • Disadvantages of Gastric Bypass
  • NEW BARIATRIC PROCEDURES
    • PRIMARY OBESITY SURGERY ENDOLUMINAL (POSE) PROCEDURE
      • Procedure Design
      • Clinical Trials
    • RESTORATIVE OBESITY SURGERY ENDOSCOPIC (ROSE) PROCEDURE
      • Procedure
      • Clinical Trials
      • Advantages of ROSE Procedure
      • ROSE Procedure: Procedure Cost
  • BENEFITS OF BARIATRIC SURGERY
  • RISKS AND COMPLICATIONS OF BARIATRIC SURGERY
    • PULMONARY EMBOLISM
    • GASTROINTESTINAL TRACT LEAK
    • BOWEL OBSTRUCTION (BLOCKAGES)
    • STRICTURE
    • BLEEDING
    • ULCER
    • GALLSTONES
    • INFECTIONS
    • CHRONIC NUTRITIONAL PROBLEMS
    • CONVERSION TO OPEN PROCEDURE
    • FAILURE OF WEIGHT LOSS
    • TOO MUCH WEIGHT LOSS
    • BODY IMAGE, EMOTIONAL LOSS AND DEPRESSION
    • NEUROPATHY
    • HYPOGLYCEMIA (LOW BLOOD SUGARS
    • KIDNEY FAILURE/STONES
    • COMPLICATIONS FROM ANESTHESIA
    • DEATH
    • OTHER COMPLICATIONS
  • BARIATRIC PROCEDURE HISTORIC AND CURRENT TRENDS
    • GLOBAL
    • TABLE 7 GLOBAL BARIATRIC PROCEDURES, THROUGH 2014 (NUMBER)
    • FIGURE 5 GLOBAL BARIATRIC PROCEDURE TYPES, 2014 (% OF ALL BARIATRIC PROCEDURES)
    • FIGURE 6 GLOBAL BARIATRIC PROCEDURE BY REGION, 2014 (% OF GLOBAL PROCEDURES)
    • NORTH AMERICA
    • TABLE 8 BARIATRIC PROCEDURE OCCURRENCE IN NORTH AMERICA, THROUGH 2014 (NO. OF PROCEDURES)
    • FIGURE 7 BARIATRIC PROCEDURE OCCURRENCE IN NORTH AMERICA, 2014 (% OF ALL BARIATRIC PROCEDURES)
  • AVERAGE PROCEDURE COST OF BARIATRIC SURGERY
  • TABLE 9 AVERAGE COST OF BARIATRIC SURGERY BY PROCEDURE TYPE ($)
    • FACTORS AFFECTING BARIATRIC SURGERY COST
  • BARIATRIC SURGERY: COMPARATIVE ANALYSIS
  • TABLE 10 COMPARATIVE ANALYSIS OF BARIATRIC SURGERY
  • HISTORY OF BARIATRIC SURGERY
    • JAW WIRING
    • JEJUNOILEAL BYPASS
    • GASTRIC PARTITIONING
    • VERTICAL BAND GASTROPLASTY (VBG)
    • GASTRIC BALLOONS

CHAPTER 6 OVERVIEW OF BARIATRIC SURGERY DEVICES

  • BARIATRIC SURGERY DEVICES
    • GASTRIC BYPASS
    • GASTRIC REMOVAL DEVICES
    • IMPLANTED GASTRIC DEVICES
      • Gastric Bands
      • Intragastric Balloons (IGB)
      • TABLE 11 PRINCIPAL TYPES OF BARIATRIC SURGERY DEVICES
  • REGULATORY STATUS OF BARIATRIC SURGERY DEVICES
    • UNITED STATES
    • EUROPEAN UNION (EU)
    • JAPAN
    • OTHER ASIA
      • China
      • Hong Kong
      • Taiwan
      • India
    • END-USER SEGMENTS

CHAPTER 7 UNMET NEED FOR OBESITY AND DIABETES TYPE 2

CHAPTER 8 BARIATRIC SURGERY MARKET ASSESSMENT

  • BARIATRIC PROCEDURES AND SERVICES MARKET
    • GLOBAL
    • TABLE 12 GLOBAL BARIATRIC PROCEDURE OCCURRENCE BY TYPE, THROUGH 2020 (NUMBER)
    • FIGURE 8 GLOBAL BARIATRIC PROCEDURE OCCURRENCE BY TYPE, 2014 AND 2020 (% OF TOTAL BARIATRIC SURGERY)
    • TABLE 13 BARIATRIC PROCEDURE OCCURRENCE BY REGION, THROUGH 2020 (NUMBER)
    • FIGURE 9 BARIATRIC PROCEDURE OCCURRENCE BY REGION, 2014 AND 2020 (% OF TOTAL BARIATRIC SURGERY)
    • NORTH AMERICA
    • TABLE 14 BARIATRIC PROCEDURE OCCURRENCE IN NORTH AMERICA, THROUGH 2020 (NUMBER)
    • FIGURE 10 BARIATRIC PROCEDURE OCCURRENCE IN NORTH AMERICA, 2014 AND 2020 (% OF TOTAL BARIATRIC SURGERY)
    • EUROPE
    • TABLE 15 BARIATRIC PROCEDURE OCCURRENCE IN EUROPE, THROUGH 2020 (NUMBER)
    • FIGURE 11 BARIATRIC PROCEDURE OCCURRENCE IN EUROPE, 2014 AND 2020 (% OF TOTAL BARIATRIC SURGERY)
    • ASIA
    • TABLE 16 BARIATRIC PROCEDURE OCCURRENCE IN ASIA, THROUGH 2020 (NUMBER)
    • FIGURE 12 BARIATRIC PROCEDURE OCCURRENCE IN ASIA, 2014 AND 2020 (% OF TOTAL BARIATRIC SURGERY)
  • PROJECTED TRENDS IN BARIATRIC SURGERY
  • BARIATRIC SURGERY DEVICES MARKET
    • GLOBAL BARIATRIC SURGERY DEVICE MARKET BY REGION
    • TABLE 17 GLOBAL BARIATRIC SURGERY DEVICE MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
    • FIGURE 13 GLOBAL BARIATRIC SURGERY DEVICE MARKET BY REGION, 2014 AND 2020 (% OF TOTAL BARIATRIC SURGERY)
    • GLOBAL BARIATRIC SURGERY DEVICES MARKET BY TYPE OF DEVICE
      • North America
      • TABLE 18 NORTH AMERICAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, THROUGH 2020 ($ MILLIONS)
      • FIGURE 14 NORTH AMERICAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, 2014 AND 2020 (% OF TOTAL BARIATRIC SURGERY)
      • Asia
      • TABLE 19 ASIAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, THROUGH 2020 ($ MILLIONS)
      • FIGURE 15 ASIAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, 2014 AND 2020 (% OF TOTAL BARIATRIC SURGERY)
      • Europe
      • TABLE 20 EUROPEAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, THROUGH 2020 ($ MILLIONS)
      • FIGURE 16 EUROPEAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, 2014 AND 2020 (% OF TOTAL BARIATRIC SURGERY)
    • GLOBAL IMPLANTED BARIATRIC SURGERY DEVICES MARKET
    • TABLE 21 GLOBAL MARKET FOR IMPLANTED DEVICES, THROUGH 2020 ($ MILLIONS)
  • MARKET GROWTH DRIVERS AND RESTRAINTS
    • GROWTH DRIVERS
      • Global Obesity Epidemic
      • Diabetes Prevalence
      • Less Invasive/Noninvasive Procedures
      • Western Food Habits and Sedentary Lifestyles
      • Reimbursement
      • Increasing Awareness in Developed Nations
      • Medical Tourism
    • GROWTH RESTRAINTS
      • Lack of Awareness, Availability and Affordability in Developing Nations
      • High Cost of Bariatric Surgery
      • Long Wait Time
      • Short-Term and Long-Term Complications

CHAPTER 9 COMPETITION AND MARKET SHARES

  • TABLE 22 GLOBAL BARIATRIC SURGERY MARKET SHARES BY COMPANY, 2014 ($ MILLIONS/%)
  • FIGURE 17 GLOBAL BARIATRIC SURGERY MARKET SHARES BY COMPANY, 2014 (% OF TOTAL MARKET)

CHAPTER 10 MARKETED, ABANDONED AND PIPELINE PRODUCTS

  • MARKETED PRODUCTS
  • TABLE 23 KEY MARKETED PRODUCTS OF BARIATRIC SURGERY DEVICES
    • VBLOC THERAPY/MAESTRO RC SYSTEM
      • General Description
      • Clinical Trials
      • Procedure
    • RESHAPE INTEGRATED DUAL BALLOON SYSTEM
    • ORBERA INTRAGASTRIC BALLOON
    • GASTRISAIL GASTRIC POSITIONING SYSTEM
    • LAP-BAND ADJUSTABLE GASTRIC BANDING SYSTEM
    • REALIZE ADJUSTABLE GASTRIC BAND
    • ENSEAL
    • PERI-STRIPS DRY WITH VERITAS
    • ENDOPATH XCEL TROCAR
    • ECHELON FLEX POWERED ARTICULATING ENDOSCOPIC LINEAR CUTTERS
    • HARMONIC ACE SHEARS + ADAPTIVE TISSUE TECHNOLOGY
    • ENDO GIA RADIAL RELOAD WITH TRI-STAPLE TECHNOLOGY
      • Endo GIA Reload
    • ENDO STITCH ENDOSCOPIC SUTURING DEVICE
    • ENDOGASTRIC SOLUTIONS STOMAPHYX DELIVERY DEVICE, FASTENERS AND ACCESSORIES
    • HELIOSPHERE BAG
    • HELIOGAST
      • Heliogast HAGE
      • Heliogast HAGA
    • ENDOCINCH
    • ENDOSURGICAL OPERATING SYSTEM (EOS)
  • ABANDONED PRODUCTS
    • GARREN-EDWARDS GASTRIC BUBBLE (GEGB)
    • TABLE 24 KEY ABANDONED/ DISCONTINUED PRODUCTS OF BARIATRIC SURGERY DEVICES
    • EASYBAND
  • PIPELINE PRODUCTS
    • ENDOBARRIER
      • General Description
      • Procedure
      • Clinical Trials
      • TABLE 25 ENDOBARRIER CLINICAL TRIALS
      • Advantages
      • Disadvantages
      • EndoBarrier: Procedure Cost
      • TABLE 26 KEY PIPELINE PRODUCTS OF BARIATRIC SURGERY DEVICES
    • VALENTX
      • General Description
      • Clinical Trials
      • TABLE 27 VALENTX CLINICAL TRIALS
      • Advantages
    • ASPIREASSIST
      • General Description
      • Clinical Trials
      • TABLE 28 ASPIREASSIST CLINICAL TRIAL
      • Procedure
    • TANTALUS SYSTEM
      • General Description
      • Clinical Trials
      • TABLE 29 TANTALUS SYSTEM CLINICAL TRIAL
      • Procedure
    • DEEP BRAIN STIMULATION SYSTEM/TRIGEMINAL NERVE STIMULATION (TNS)-OBESITY
      • General Description
      • Clinical Trials
      • TABLE 30 TRIGEMINAL NERVE STIMULATION (TNS) CLINICAL TRIAL
    • ELIPSE
      • General Description
      • Procedure
    • FULL SENSE DEVICE
      • General Description
      • Procedure
      • Clinical Trials
    • SAMSEN MAGNETS
      • General Description
      • Procedure
    • GASTRIC VEST SYSTEM
      • General Description
      • Procedure
    • OBALON BALLOON
      • General Description
      • Procedure
      • Clinical Trials
    • SMART DEVICE
      • General Description
      • Procedure
    • INTRAGASTRIC BALLOON
      • General Description
      • Procedure
    • DIGESTIBLE BALLOON
      • General Description
      • Clinical Trials
    • SPATZ3 ADJUSTABLE BALLOON SYSTEM
      • General Description
      • Procedure
      • Clinical Trials
    • ENDORETICS DEVICE
      • General Description
      • Procedure
      • ATTIVA
    • NOBESE DEVICE
      • General Description
      • Procedure
    • SATISPHERE
      • General Description
      • Clinical Trials
      • Procedure
    • SILIMED GASTRIC BALLOON
      • General Description
      • Procedure
      • Clinical Trial
      • TABLE 31 SILIMED GASTRIC BALLOON CLINICAL TRIAL
    • TRANSPYLORIC SHUTTLE
      • General Description
      • Clinical Trials
      • TABLE 32 TRANSPYLORIC SHUTTLE DEVICE CLINICAL TRIAL
      • Procedure
    • TOGA SYSTEM
      • General Description
      • Clinical Trials
      • TABLE 33 TOGA SYSTEM CLINICAL TRIALS
      • Procedure
    • SENSATE ANCHORED GASTRIC DEVICE
      • General Description
      • Procedure
      • Clinical Trial
      • TABLE 34 SENSATE ANCHORED GASTRIC DEVICE CLINICAL TRIAL
    • ABILITI
      • General Description
      • Clinical Trials
      • TABLE 35 ABILITI SYSTEM CLINICAL TRIALS

CHAPTER 11 REIMBURSEMENT

  • GENERAL REIMBURSEMENT CRITERIA
  • UNITED STATES
    • ICD-9-CM
    • TABLE 36 BARIATRIC SURGERY, INTERNATIONAL CLASSIFICATION OF DISEASES, NINTH REVISION (ICD-9) CODES
    • TABLE 37 COVERED INPATIENT FACILITY ICD-9-CM PROCEDURE CODES
    • ICD-10
  • EUROPE
  • JAPAN
  • OTHER ASIA

CHAPTER 12 CONCLUSIONS: THE OUTLOOK FOR BARIATRIC SURGERY DEVICES

  • MAJOR DEVELOPMENTS THAT WILL INFLUENCE THE BARIATRIC SURGERY MARKET
    • TECHNOLOGICAL DEVELOPMENTS
      • Adaptation of Minimally Invasive Techniques to New Types of Surgical Procedures
      • Endoluminal Procedures
      • Gastric Stimulators
      • New Designs of Gastric Balloons
    • DEMOGRAPHIC AND ECONOMIC TRENDS
      • Growing Obesity Populations Worldwide
      • TABLE 38 TRENDS IN OBESITY COMPOSITION OF THE WORLD'S POPULATION, THROUGH 2020 (MILLIONS)
      • TABLE 39 U.S. OBESITY AND SEVERE OBESITY VS GENERAL POPULATION, THROUGH 2020 (MILLIONS)
      • Income Growth in Developing Markets
      • TABLE 40 TRENDS IN PER CAPITA REAL GDP GROWTH BY REGION, 2012-2015 (ANNUAL AVERAGE PERCENTAGE CHANGE)
    • CHANGING STRUCTURE OF THE HEALTH CARE INDUSTRY
      • Hospital Consolidation
      • Medical Tourism
      • Health Insurance Developments
  • LONG-TERM OUTLOOK FOR BARIATRIC SURGERY DEVICES AND SERVICES

CHAPTER 13 APPENDIX A: ABBREVIATIONS

CHAPTER 14 COMPANY PROFILES

  • ALLURION TECHNOLOGIES
  • A.M.I. (AGENCY FOR MEDICAL INNOVATIONS)
  • APOLLO ENDOSURGERY
  • APPLIED MEDICAL
  • ASPIRE BARIATRICS
  • BARONOVA
  • BAROSENSE (SUBSIDIARY OF BOSTON SCIENTIFIC)
  • BAXTER
  • BETA-STIM
  • BFKW
  • COOK GROUP
  • C.R. BARD
  • CROSPON
  • ENDOGASTRIC SOLUTIONS
  • ENDORETICS
  • ENDOBETIX
  • ENDOSPHERE
  • ENTEROMEDICS
  • ETHICON ENDO-SURGERY (SUBSIDIARY OF JOHNSON & JOHNSON)
  • GELESIS
  • GI DYNAMICS
  • GI WINDOWS
  • HELIOSCOPIE
  • INTRAPACE INC.
  • MEDTRONIC
  • METACURE
  • OBALON THERAPEUTICS
  • ONCIOMED
  • PLENSAT
  • RESHAPE MEDICAL
  • SARL COUSIN BIOTECH
  • SATIETY
  • SCIENTIFIC INTAKE
  • SENSATE
  • SILHOUETTE MEDICAL
  • SKLAR
  • SLIMEDICS
  • SPATZ FGIA
  • TRANSENTERIX
  • TULIP MEDICAL
  • USGI MEDICAL
  • VALENTX
  • W. L. GORE

CHAPTER 15 APPENDIX C: INDUSTRY AND PROFESSIONAL ORGANIZATIONS

  • THE AMERICAN SOCIETY FOR METABOLIC AND BARIATRIC SURGERY (ASMBS)
  • EUROPEAN ASSOCIATION FOR ENDOSCOPIC SURGERY (EAES)
  • INTERNATIONAL ASSOCIATION FOR THE STUDY OF OBESITY
  • INTERNATIONAL DIABETES FEDERATION (IDF)
  • INTERNATIONAL FEDERATION FOR THE SURGERY OF OBESITY AND METABOLIC DISORDERS
  • INTERNATIONAL OBESITY TASK FORCE (IOTF)
  • OBESITY IN AMERICA
  • THE OBESITY SOCIETY
  • SOCIETY OF AMERICAN GASTROINTESTINAL ENDOSCOPIC SURGEONS (SAGES)
  • SOCIETY OF LAPAROENDOSCOPIC SURGEONS (SLS)

LIST OF TABLES

  • SUMMARY TABLE GLOBAL MARKET FOR BARIATRIC SURGERY BY REGION, THROUGH 2020 ($ MILLIONS)
  • TABLE 1 BMI CALCULATION
  • TABLE 2 BMI CATEGORIES BASED ON INCREASING HEALTH RISKS
  • TABLE 3 GLOBAL OBESE POPULATION AND SEVERE OBESE POPULATION VS. GENERAL POPULATION, THROUGH 2014 (MILLIONS)
  • TABLE 4 U.S. OBESITY AND SEVERE OBESITY VS. GENERAL POPULATION, THROUGH 2014 (MILLIONS)
  • TABLE 5 GLOBAL DIABETES PREVALENCE, THROUGH 2030 (BILLIONS/%/MILLIONS)
  • TABLE 6 TYPES OF BARIATRIC SURGERIES
  • TABLE 7 GLOBAL BARIATRIC PROCEDURES, THROUGH 2014 (NUMBER)
  • TABLE 8 BARIATRIC PROCEDURE OCCURRENCE IN NORTH AMERICA, THROUGH 2014 (NO. OF PROCEDURES)
  • TABLE 9 AVERAGE COST OF BARIATRIC SURGERY BY PROCEDURE TYPE ($)
  • TABLE 10 COMPARATIVE ANALYSIS OF BARIATRIC SURGERY
  • TABLE 11 PRINCIPAL TYPES OF BARIATRIC SURGERY DEVICES
  • TABLE 12 GLOBAL BARIATRIC PROCEDURE OCCURRENCE BY TYPE, THROUGH 2020 (NUMBER)
  • TABLE 13 BARIATRIC PROCEDURE OCCURRENCE BY REGION, THROUGH 2020 (NUMBER)
  • TABLE 14 BARIATRIC PROCEDURE OCCURRENCE IN NORTH AMERICA, THROUGH 2020 (NUMBER)
  • TABLE 15 BARIATRIC PROCEDURE OCCURRENCE IN EUROPE, THROUGH 2020 (NUMBER)
  • TABLE 16 BARIATRIC PROCEDURE OCCURRENCE IN ASIA, THROUGH 2020 (NUMBER)
  • TABLE 17 GLOBAL BARIATRIC SURGERY DEVICE MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
  • TABLE 18 NORTH AMERICAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, THROUGH 2020 ($ MILLIONS)
  • TABLE 19 ASIAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, THROUGH 2020 ($ MILLIONS)
  • TABLE 20 EUROPEAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, THROUGH 2020 ($ MILLIONS)
  • TABLE 21 GLOBAL MARKET FOR IMPLANTED DEVICES, THROUGH 2020 ($ MILLIONS)
  • TABLE 22 GLOBAL BARIATRIC SURGERY MARKET SHARES BY COMPANY, 2014 ($ MILLIONS/%)
  • TABLE 23 KEY MARKETED PRODUCTS OF BARIATRIC SURGERY DEVICES
  • TABLE 24 KEY ABANDONED/ DISCONTINUED PRODUCTS OF BARIATRIC SURGERY DEVICES
  • TABLE 25 ENDOBARRIER CLINICAL TRIALS
  • TABLE 26 KEY PIPELINE PRODUCTS OF BARIATRIC SURGERY DEVICES
  • TABLE 27 VALENTX CLINICAL TRIALS
  • TABLE 28 ASPIREASSIST CLINICAL TRIAL
  • TABLE 29 TANTALUS SYSTEM CLINICAL TRIAL
  • TABLE 30 TRIGEMINAL NERVE STIMULATION (TNS) CLINICAL TRIAL
  • TABLE 31 SILIMED GASTRIC BALLOON CLINICAL TRIAL
  • TABLE 32 TRANSPYLORIC SHUTTLE DEVICE CLINICAL TRIAL
  • TABLE 33 TOGA SYSTEM CLINICAL TRIALS
  • TABLE 34 SENSATE ANCHORED GASTRIC DEVICE CLINICAL TRIAL
  • TABLE 35 ABILITI SYSTEM CLINICAL TRIALS
  • TABLE 36 BARIATRIC SURGERY, INTERNATIONAL CLASSIFICATION OF DISEASES, NINTH REVISION (ICD-9) CODES
  • TABLE 37 COVERED INPATIENT FACILITY ICD-9-CM PROCEDURE CODES
  • TABLE 38 TRENDS IN OBESITY COMPOSITION OF THE WORLD'S POPULATION, THROUGH 2020 (MILLIONS)
  • TABLE 39 U.S. OBESITY AND SEVERE OBESITY VS GENERAL POPULATION, THROUGH 2020 (MILLIONS)
  • TABLE 40 TRENDS IN PER CAPITA REAL GDP GROWTH BY REGION, 2012-2015 (ANNUAL AVERAGE PERCENTAGE CHANGE)

LIST OF FIGURES

  • SUMMARY FIGURE GLOBAL MARKET FOR BARIATRIC SURGERY BY REGION, 2014-2020 ($ MILLIONS)
  • FIGURE 1 ENERGY BALANCE, 2014
  • FIGURE 2 GLOBAL OBESE POPULATION AND SEVERE OBESE POPULATION, 2008 AND 2014 (% OF GLOBAL GENERAL POPULATION)
  • FIGURE 3 GLOBAL DIABETES TYPES (% OF TOTAL DIABETES)
  • FIGURE 4 GLOBAL OPEN VS. LAPAROSCOPIC BARIATRIC SURGERY OCCURRENCE, 2014 (% OF TOTAL BARIATRIC PROCEDURES)
  • FIGURE 5 GLOBAL BARIATRIC PROCEDURE TYPES, 2014 (% OF ALL BARIATRIC PROCEDURES)
  • FIGURE 6 GLOBAL BARIATRIC PROCEDURE BY REGION, 2014 (% OF GLOBAL PROCEDURES)
  • FIGURE 7 BARIATRIC PROCEDURE OCCURRENCE IN NORTH AMERICA, 2014 (% OF ALL BARIATRIC PROCEDURES)
  • FIGURE 8 GLOBAL BARIATRIC PROCEDURE OCCURRENCE BY TYPE, 2014 AND 2020 (% OF TOTAL BARIATRIC SURGERY)
  • FIGURE 9 BARIATRIC PROCEDURE OCCURRENCE BY REGION, 2014 AND 2020 (% OF TOTAL BARIATRIC SURGERY)
  • FIGURE 10 BARIATRIC PROCEDURE OCCURRENCE IN NORTH AMERICA, 2014 AND 2020 (% OF TOTAL BARIATRIC SURGERY)
  • FIGURE 11 BARIATRIC PROCEDURE OCCURRENCE IN EUROPE, 2014 AND 2020 (% OF TOTAL BARIATRIC SURGERY)
  • FIGURE 12 BARIATRIC PROCEDURE OCCURRENCE IN ASIA, 2014 AND 2020 (% OF TOTAL BARIATRIC SURGERY)
  • FIGURE 13 GLOBAL BARIATRIC SURGERY DEVICE MARKET BY REGION, 2014 AND 2020 (% OF TOTAL BARIATRIC SURGERY)
  • FIGURE 14 NORTH AMERICAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, 2014 AND 2020 (% OF TOTAL BARIATRIC SURGERY)
  • FIGURE 15 ASIAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, 2014 AND 2020 (% OF TOTAL BARIATRIC SURGERY)
  • FIGURE 16 EUROPEAN BARIATRIC SURGERY MARKET BY DEVICE TYPE, 2014 AND 2020 (% OF TOTAL BARIATRIC SURGERY)
  • FIGURE 17 GLOBAL BARIATRIC SURGERY MARKET SHARES BY COMPANY, 2014 (% OF TOTAL MARKET)
Back to Top